Timothy Klein

The cost effectiveness of teriparatide as a first-line treatment for glucocorticoid-induced and postmenopausal osteoporosis patients in Sweden

Daniel R. Murphy, Lee Smolen, Timothy Klein et al. · BMC Musculoskeletal Disorders · 2012 · 49 citations · Full text

Pharmacy, Pharmacoeconomics, Pharmacotherapy +17

Cost-effectiveness of several atypical antipsychotics in orally disintegrating tablets compared with standard oral tablets in the treatment of schizophrenia in the United States

Haya Ascher‐Svanum, Nicolas M. Furiak, Anthony H. Lawson et al. · Journal of Medical Economics · 2012 · 36 citations

Pharmacy, Pharmacoeconomics, Pharmacotherapy +17

Mirabegron for the treatment of overactive bladder: cost-effectiveness from US commercial health-plan and Medicare Advantage perspectives

Ronald C. Wielage, Sinem Perk, Noll L. Campbell et al. · Journal of Medical Economics · 2016 · 32 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

Component Costs of CAR-T Therapy in Addition to Treatment Acquisition Costs in Patients with Multiple Myeloma

Sundar Jagannath, N.R. Joseph, Concetta Crivera et al. · Oncology and Therapy · 2023 · 31 citations · Full text

Life Sciences, Immunology, Pharmacoeconomics +17

The Outcomes of an Inpatient Treatment Program for Geriatric Patients With Dementia and Dysfunctional Behaviors

A. Holm, M. Michel, G Stern et al. · The Gerontologist · 1999 · 26 citations · Full text

Medicine, Behavioral Sciences, Geriatric Medicine +17